EMA to assess conditional authorisation of first COVID-19 treatment in European Union
The assessment of the benefits and risks of remdesivir is being performed under a reduced timeline and an opinion could be issued…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
CSIR’s anti-cancer drug IIIM-290 goes into clinical trial
The clinical trial aims to assess safety, tolerability and exposure of the compound in humans along with the early efficacy…
NIPER Guwahati and HAL sign MOU for industrial grade 3D antimicrobial face-shields
NIPER-G has designed, developed and validated these face-shields to control the spread of novel coronavirus after analyses of…
There will be a positive impact of the coronavirus on our balance sheet
The nationwide lockdown due to the COVID-19 pandemic has impacted business operations across sectors. However, the Sami-Sabinsa …
There is an urgent need to revive the Ancillary industry: IPA
IPA in collaboration with Accenture has conducted a study that details out the best ways to revive the Pharma Ancillary Industry…
Telangana DCA issues approx 110 licenses for manufacturing hand sanitisers
Approves only those based on CDSCO-approved compositions
Intravacc and Versatope to develop universal influenza vaccine based on OMV technology
According to Centers for Disease Control and Prevention, influenza vaccines were overall 29 per cent effective during the…
Gland Pharma launches of the first non-frozen ready-to-use Bivalirudin
Bivalirudin RTU Injection is indicated for use as an anticoagulant in patients undergoing percutaneous coronary intervention
Marksons Pharma voluntarily recalls a batch of Metformin XR tablets
It is due to the detection of NDMA
AYUSH Ministry to act against misleading COVID-19 products
Industry experts express the need for amendments and clarity in existing regulations for AYUSH products in the larger public…